0001140361-15-019184.txt : 20150512
0001140361-15-019184.hdr.sgml : 20150512
20150512183711
ACCESSION NUMBER: 0001140361-15-019184
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150508
FILED AS OF DATE: 20150512
DATE AS OF CHANGE: 20150512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OPGEN INC
CENTRAL INDEX KEY: 0001293818
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 061614015
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 708 QUINCE ORCHARD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 301-869-9683
MAIL ADDRESS:
STREET 1: 708 QUINCE ORCHARD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ATWOOD BRIAN G
CENTRAL INDEX KEY: 0001266567
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37367
FILM NUMBER: 15855911
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
4
1
doc1.xml
FORM 4
X0306
4
2015-05-08
0
0001293818
OPGEN INC
OPGN,OPGNW
0001266567
ATWOOD BRIAN G
ONE SANSOME STREET, SUITE 3630
SAN FRANCISCO
CA
94104
1
0
1
0
Common Stock
2015-05-08
4
P
0
413332
6.00
A
485925
I
See footnote
Common Stock
2015-05-08
4
C
0
1160039
A
1645964
I
See footnote
Common Stock
2015-05-08
4
C
0
404725
A
2050689
I
See footnote
Common Stock
2015-05-08
4
C
0
503522
A
2554211
I
See footnote
Series A Redeemable Convertible Preferred Stock
2015-05-08
4
C
0
1160039
0.00
D
Common Stock
1160039
0
I
See footnote
2014 Convertible Notes
2015-05-08
4
C
0
404725
0.00
D
Common Stock
404725
0
I
See footnote
2015 Convertible Notes
2015-05-08
4
C
0
503522
0.00
D
Common Stock
503522
0
I
See footnote
Warrants
6.60
2015-05-08
4
P
0
413332
0.00
A
2015-05-08
2020-05-08
Common Stock
413332
413332
I
See footnote
Series A Redeemable Convertible Preferred Stock automatically converted into common stock on a 1-to-1 basis upon the consummation of the Company's initial public offering.
The 2014 Convertible Notes automatically converted into shares of Series A Preferred Stock upon the consummation of the Company's initial public offering at a conversion rate of one share of Series A Preferred Stock for every $1.00 of principal converted. Each share of Series A Preferred Stock automatically converted into one share of common stock upon the consummation of the Company's initial public offering.
The 2015 Convertible Notes converted into Series A Preferred Stock upon the consummation of the Company's initial public offering at a conversion rate of 1.25 shares of Series A Preferred Stock for each $1.00 of principal converted. Each share of Series A Preferred stock automatically converted into one share of common stock upon the consummation of the Company's initial public offering.
The securities are directly held by Versant Venture Capital III, L.P. and Versant Side Fund III, L.P. (collectively, the "Versant Entities"). Mr. Atwood is a managing member of Versant Ventures III, LLC, the sole general partner of the Versant Entities and may be deemed to have shared voting and dispositive power over the shares owned by the Versant Entities. Mr. Atwood disclaims beneficial ownership of all shares held by the Versant Entities, except to the extent of his actual pecuniary interest therein.
/s/ Timothy C. Dec, Attorney-in-Fact
2015-05-12